Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1998 May 1;17(9):2463–2471. doi: 10.1093/emboj/17.9.2463

Crystal structure of human uroporphyrinogen decarboxylase.

F G Whitby 1, J D Phillips 1, J P Kushner 1, C P Hill 1
PMCID: PMC1170588  PMID: 9564029

Abstract

Uroporphyrinogen decarboxylase (URO-D) catalyzes the fifth step in the heme biosynthetic pathway, converting uroporphyrinogen to coproporphyrinogen by decarboxylating the four acetate side chains of the substrate. This activity is essential in all organisms, and subnormal activity of URO-D leads to the most common form of porphyria in humans, porphyria cutanea tarda (PCT). We have determined the crystal structure of recombinant human URO-D at 1.60 A resolution. The 40.8 kDa protein is comprised of a single domain containing a (beta/alpha)8-barrel with a deep active site cleft formed by loops at the C-terminal ends of the barrel strands. Many conserved residues cluster at this cleft, including the invariant side chains of Arg37, Arg41 and His339, which probably function in substrate binding, and Asp86, Tyr164 and Ser219, which may function in either binding or catalysis. URO-D is a dimer in solution (Kd = 0.1 microM), and this dimer also appears to be formed in the crystal. Assembly of the dimer juxtaposes the active site clefts of the monomers, suggesting a functionally important interaction between the catalytic centers.

Full Text

The Full Text of this article is available as a PDF (904.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnard G. F., Akhtar M. Stereochemical and mechanistic studies on the decarboxylation of uroporphyrinogen III in haem biosynthesis. J Chem Soc Perkin 1. 1979;10:2354–2360. doi: 10.1039/p19790002354. [DOI] [PubMed] [Google Scholar]
  2. Chelstowska A., Zoladek T., Garey J., Kushner J., Rytka J., Labbe-Bois R. Identification of amino acid changes affecting yeast uroporphyrinogen decarboxylase activity by sequence analysis of hem12 mutant alleles. Biochem J. 1992 Dec 15;288(Pt 3):753–757. doi: 10.1042/bj2880753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elder G. H., Lee G. B., Tovey J. A. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med. 1978 Aug 10;299(6):274–278. doi: 10.1056/NEJM197808102990603. [DOI] [PubMed] [Google Scholar]
  4. Garey J. R., Franklin K. F., Brown D. A., Harrison L. M., Metcalf K. M., Kushner J. P. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology. 1993 Jul;105(1):165–169. doi: 10.1016/0016-5085(93)90022-5. [DOI] [PubMed] [Google Scholar]
  5. Garey J. R., Hansen J. L., Harrison L. M., Kennedy J. B., Kushner J. P. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood. 1989 Mar;73(4):892–895. [PubMed] [Google Scholar]
  6. Holm L., Sander C. Dali/FSSP classification of three-dimensional protein folds. Nucleic Acids Res. 1997 Jan 1;25(1):231–234. doi: 10.1093/nar/25.1.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hutchinson E. G., Thornton J. M. PROMOTIF--a program to identify and analyze structural motifs in proteins. Protein Sci. 1996 Feb;5(2):212–220. doi: 10.1002/pro.5560050204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jackson A. H., Sancovich H. A., Ferramola A. M., Evans N., Games D. E., Matlin S. A., Elder G. H., Smith S. G. Macrocyclic intermediates in the biosynthesis of porphyrins. Philos Trans R Soc Lond B Biol Sci. 1976 Feb 5;273(924):191–206. doi: 10.1098/rstb.1976.0009. [DOI] [PubMed] [Google Scholar]
  9. Johnston S. C., Larsen C. N., Cook W. J., Wilkinson K. D., Hill C. P. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J. 1997 Jul 1;16(13):3787–3796. doi: 10.1093/emboj/16.13.3787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  11. Kawanishi S., Seki Y., Sano S. Uroporphyrinogen decarboxylase. Purification, properties, and inhibition by polychlorinated biphenyl isomers. J Biol Chem. 1983 Apr 10;258(7):4285–4292. [PubMed] [Google Scholar]
  12. Kushner J. P., Barbuto A. J., Lee G. R. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest. 1976 Nov;58(5):1089–1097. doi: 10.1172/JCI108560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lesk A. M., Brändén C. I., Chothia C. Structural principles of alpha/beta barrel proteins: the packing of the interior of the sheet. Proteins. 1989;5(2):139–148. doi: 10.1002/prot.340050208. [DOI] [PubMed] [Google Scholar]
  14. Lim L. W., Shamala N., Mathews F. S., Steenkamp D. J., Hamlin R., Xuong N. H. Three-dimensional structure of the iron-sulfur flavoprotein trimethylamine dehydrogenase at 2.4-A resolution. J Biol Chem. 1986 Nov 15;261(32):15140–15146. [PubMed] [Google Scholar]
  15. Luo J., Lim C. K. Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase. Biochem J. 1993 Jan 15;289(Pt 2):529–532. doi: 10.1042/bj2890529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matthews B. W. Solvent content of protein crystals. J Mol Biol. 1968 Apr 28;33(2):491–497. doi: 10.1016/0022-2836(68)90205-2. [DOI] [PubMed] [Google Scholar]
  17. McManus J. F., Begley C. G., Sassa S., Ratnaike S. Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria. Blood. 1996 Nov 1;88(9):3589–3600. [PubMed] [Google Scholar]
  18. Meguro K., Fujita H., Ishida N., Akagi R., Kurihara T., Galbraith R. A., Kappas A., Zabriskie J. B., Toback A. C., Harber L. C. Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Invest Dermatol. 1994 May;102(5):681–685. doi: 10.1111/1523-1747.ep12374134. [DOI] [PubMed] [Google Scholar]
  19. Moran-Jimenez M. J., Ged C., Romana M., Enriquez De Salamanca R., Taïeb A., Topi G., D'Alessandro L., de Verneuil H. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet. 1996 Apr;58(4):712–721. [PMC free article] [PubMed] [Google Scholar]
  20. Murzin A. G., Lesk A. M., Chothia C. Principles determining the structure of beta-sheet barrels in proteins. II. The observed structures. J Mol Biol. 1994 Mar 11;236(5):1382–1400. doi: 10.1016/0022-2836(94)90065-5. [DOI] [PubMed] [Google Scholar]
  21. Nishimura K., Nakayashiki T., Inokuchi H. Cloning and sequencing of the hemE gene encoding uroporphyrinogen III decarboxylase (UPD) from Escherichia coli K-12. Gene. 1993 Oct 29;133(1):109–113. doi: 10.1016/0378-1119(93)90233-s. [DOI] [PubMed] [Google Scholar]
  22. Phillips J. D., Whitby F. G., Kushner J. P., Hill C. P. Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci. 1997 Jun;6(6):1343–1346. doi: 10.1002/pro.5560060624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ramakrishnan V., Biou V. Treatment of multiwavelength anomalous diffraction data as a special case of multiple isomorphous replacement. Methods Enzymol. 1997;276:538–557. [PubMed] [Google Scholar]
  24. Romana M., Grandchamp B., Dubart A., Amselem S., Chabret C., Nordmann Y., Goossens M., Romeo P. H. Identification of a new mutation responsible for hepatoerythropoietic porphyria. Eur J Clin Invest. 1991 Apr;21(2):225–229. doi: 10.1111/j.1365-2362.1991.tb01814.x. [DOI] [PubMed] [Google Scholar]
  25. Roméo P. H., Raich N., Dubart A., Beaupain D., Pryor M., Kushner J., Cohen-Solal M., Goossens M. Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J Biol Chem. 1986 Jul 25;261(21):9825–9831. [PubMed] [Google Scholar]
  26. Seki Y., Kawanishi S., Sano S. Uroporphyrinogen decarboxylase purification from chicken erythrocytes. Methods Enzymol. 1986;123:415–421. doi: 10.1016/s0076-6879(86)23051-7. [DOI] [PubMed] [Google Scholar]
  27. Sergeev Y., Lee B. Alignment of beta-barrels in (beta/alpha)8 proteins using hydrogen-bonding pattern. J Mol Biol. 1994 Nov 25;244(2):168–182. doi: 10.1006/jmbi.1994.1717. [DOI] [PubMed] [Google Scholar]
  28. Straka J. G., Kushner J. P., Pryor M. A. Uroporphyrinogen decarboxylase. A method for measuring enzyme activity. Enzyme. 1982;28(2-3):170–185. [PubMed] [Google Scholar]
  29. Wyckoff E. E., Phillips J. D., Sowa A. M., Franklin M. R., Kushner J. P. Mutational analysis of human uroporphyrinogen decarboxylase. Biochim Biophys Acta. 1996 Dec 5;1298(2):294–304. doi: 10.1016/s0167-4838(96)00148-3. [DOI] [PubMed] [Google Scholar]
  30. de Verneuil H., Grandchamp B., Foubert C., Weil D., N'Guyen V. C., Gross M. S., Sassa S., Nordmann Y. Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay. Hum Genet. 1984;66(2-3):202–205. doi: 10.1007/BF00286601. [DOI] [PubMed] [Google Scholar]
  31. de Verneuil H., Grandchamp B., Nordmann Y. Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochim Biophys Acta. 1980 Jan 11;611(1):174–186. doi: 10.1016/0005-2744(80)90053-4. [DOI] [PubMed] [Google Scholar]
  32. de Verneuil H., Hansen J., Picat C., Grandchamp B., Kushner J., Roberts A., Elder G., Nordmann Y. Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tarda. Hum Genet. 1988 Jan;78(1):101–102. doi: 10.1007/BF00291248. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES